Jones Financial Companies’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.9K Sell
671
-177
-21% -$6.37K ﹤0.01% 3332
2026
Q1
$20.5K Sell
848
-114
-12% -$2.7K ﹤0.01% 3284
2025
Q4
$23.9K Buy
962
+498
+107% +$13.2K ﹤0.01% 2852
2025
Q3
$13.8K Buy
464
+200
+76% +$5.42K ﹤0.01% 2958
2025
Q2
$6.53K Buy
264
+14
+6% +$394 ﹤0.01% 3041
2025
Q1
$7.63K Hold
250
– – ﹤0.01% 2820
2024
Q4
$7.88K Buy
+250
New +$11.9K ﹤0.01% 2612

Other funds holding ASTH

Jones Financial Companies's ASTH Position: Q2 2026 in Review

Jones Financial Companies reduced its Astrana Health (ASTH) stake by 21% in Q2 2026, selling an estimated $6.37K and leaving 671 shares worth $29.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3332.

Jones Financial Companies first reported a position in ASTH in Q4 2024 and has held it in 7 quarters since. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Jones Financial Companies held 671 shares of Astrana Health worth $29.9K as of Q2 2026.
  • Jones Financial Companies sold 177 Astrana Health shares in Q2 2026, an estimated $6.37K.
  • Astrana Health made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #3332 holding.
  • Jones Financial Companies first reported a position in Astrana Health in Q4 2024 and has held it in 7 quarters since.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.